MANAGEMENT OF CORONARY ARTERY DISEASE IN PATIENT WITH DIABETES
Jambukumar G.*, Leelavathi K., Arulkumar A., Sanjay S., Sivarajkumar S., Ponsivasankar M., Pavithra G. and Dr. A Suresh
Abstract
This review's objective is to go through the unique characteristics of
Coronary Artery Disease; the impact of aggressive medicinal treatment
and the results of Percutaneous and Surgical revascularization in
people with Diabetes Mellitus. Coronary artery disease are
significantly more prevalent in people with diabetes mellitus.
According to various diagnostic techniques, the prevalence of CAD in
adults with DM can reach up to 55%, compared to 2% to 4% in the
general population.[1] A separate risk factor for increased mortality and
morbidity is diabetes mellitus.[1–4] Men and women with DM have
cardiovascular mortality rates that are more than twice as high as those
of non-diabetics,[2,4] and these patients also have patients with a worse
post-MI prognosis.[5–8] Additionally, it is known that diabetes mellitus
increases the risk of a poor outcome from either percutaneous[9–17] or surgical[18–22] coronary
revascularization. However, diabetics make up to 25% of patients who are referred for such
procedures[9-13,15,22-27] Despite significant recent advancements in these procedures, there is
still debate over the best therapeutic approach for diabetics.[14,17] In particular, the clinical,
angiographic, metabolic, and biological characteristics of CAD in diabetics are covered in
this review. In an effort to decide on the best therapeutic approach for this patient population, it also covers the effects of intensive medical management and the early and late outcomes following percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG).
Keywords: Coronary Heart disease, Diabetes, CABG, PTCA, Coronary revascularization.
[Full Text Article]